HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Specific demonstration of drug-induced tumour cell apoptosis in human xenografts models using a plasma biomarker.

Abstract
Pharmacodynamic (PD) assays should be used before advancing new drugs to clinical trials. Most PD assays measure the response to drugs in tissue, a procedure which requires tissue biopsies. The M30-Apoptosense ELISA is a PD biomarker assay for the quantitative determination of caspase-cleaved cytokeratin 18 (CK18) released from apoptotic carcinoma cells into blood. We here demonstrate that whereas the M30-Apoptosense ELISA assay detects human caspase-cleaved CK18, the mouse and rat CK18 caspase cleavage products are detected with low affinity. The M30-Apoptosense ELISA therefore facilitates the determination of drug-induced apoptosis in human tumour xenografts in rodents using plasma samples, largely independently from host toxicity. Increases of caspase-cleaved CK18 were observed in plasma from different carcinoma xenograft models in response to anticancer drugs. The appearance caspase-cleaved CK18 in plasma was found to reflect formation of the caspase-cleaved epitope in FaDu head-neck carcinomas and in cultured cells. The M30-Apoptosense assay allows determination of tumour response in blood from xenograft models and from patients, providing a powerful tool for translational studies of anticancer drugs.
AuthorsM Hägg Olofsson, J Cummings, W Fayad, S Brnjic, R Herrmann, M Berndtsson, C Hodgkinson, E Dean, R Odedra, R W Wilkinson, K E Mundt, M Busk, C Dive, S Linder
JournalCancer biomarkers : section A of Disease markers (Cancer Biomark) Vol. 5 Issue 3 Pg. 117-25 ( 2009) ISSN: 1574-0153 [Print] Netherlands
PMID19407366 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Keratin-18
  • Peptide Fragments
  • Doxorubicin
  • Caspases
Topics
  • Amino Acid Sequence
  • Animals
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Biomarkers, Tumor (analysis, blood, metabolism)
  • Caspases (metabolism)
  • Cell Line, Tumor
  • Colonic Neoplasms (blood, drug therapy, pathology)
  • Doxorubicin (pharmacology)
  • Enzyme-Linked Immunosorbent Assay
  • HT29 Cells
  • Head and Neck Neoplasms (blood, drug therapy, pathology)
  • Humans
  • Immunohistochemistry
  • Keratin-18 (analysis, blood, metabolism)
  • Male
  • Mice
  • Mice, SCID
  • Neoplasms, Experimental (blood, drug therapy, pathology)
  • Peptide Fragments (analysis, blood)
  • Rats
  • Rats, Nude
  • Xenograft Model Antitumor Assays (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: